1. Home
  2. Labeler Index
  3. Merck Sharp & Dohme Llc
  4. 0006-3822
  5. NDC Package Code: 0006-3822-10 Cancidas

NDC Package 0006-3822-10 Cancidas

Caspofungin Acetate Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0006-3822-10
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 10.8 mL in 1 VIAL, SINGLE-USE
Product Code:
0006-3822
Proprietary Name:
Cancidas
Non-Proprietary Name:
Caspofungin Acetate
Substance Name:
Caspofungin Acetate
Usage Information:
Caspofungin is used to treat a variety of fungal infections. Caspofungin belongs to a class of drugs known as echinocandins. It works by stopping the growth of fungi.
11-Digit NDC Billing Format:
00006382210
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 828539 - caspofungin acetate 70 MG Injection
  • RxCUI: 828539 - caspofungin acetate 70 MG (equivalent to caspofungin 75.6 MG) Injection
  • RxCUI: 828541 - Cancidas 70 MG Injection
  • RxCUI: 828541 - caspofungin acetate 70 MG Injection [Cancidas]
  • RxCUI: 828541 - Cancidas 70 MG (equivalent to caspofungin 75.6 MG) Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Merck Sharp & Dohme Llc
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • CASPOFUNGIN ACETATE 5 mg/mL
    • Pharmacologic Class(es):
  • Echinocandin Antifungal - [EPC] (Established Pharmacologic Class)
  • Lipopeptides - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA021227
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    01-26-2001
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0006-3822-10 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00006382210J0637Caspofungin acetate5 MG111010

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0006-3822-10?

    The NDC Packaged Code 0006-3822-10 is assigned to a package of 1 vial, single-use in 1 carton / 10.8 ml in 1 vial, single-use of Cancidas, a human prescription drug labeled by Merck Sharp & Dohme Llc. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 0006-3822 included in the NDC Directory?

    Yes, Cancidas with product code 0006-3822 is active and included in the NDC Directory. The product was first marketed by Merck Sharp & Dohme Llc on January 26, 2001 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0006-3822-10?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0006-3822-10?

    The 11-digit format is 00006382210. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20006-3822-105-4-200006-3822-10